Genvor Inc

$ Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224002475 Filed on January 16, 2024

Income Statement

Concept	2024 Q1	2023 Q3	2023

Balance Sheet

Concept	2024 Q1	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.920K	$44.35K	$44.35K
YoY Change	490.73%		-85.04%
Cash & Equivalents	$8.923K	$44.35K
Short-Term Investments
Other Short-Term Assets	$9.980K		$21.98K
YoY Change	-35.18%		999.0%
Inventory
Prepaid Expenses	$9.975K	$21.98K
Receivables
Other Receivables
Total Short-Term Assets	$18.90K	$66.33K	$66.33K
YoY Change	11.76%	-77.77%	-77.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.82K	$15.73K	$15.73K
YoY Change	-11.0%	-10.42%	-10.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$14.82K	$15.73K	$15.73K
YoY Change	-11.0%	-10.43%	-10.42%
TOTAL ASSETS
Total Short-Term Assets	$18.90K	$66.33K	$66.33K
Total Long-Term Assets	$14.82K	$15.73K	$15.73K
Total Assets	$33.72K	$82.06K	$82.06K
YoY Change	0.46%	-74.03%	-74.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$181.0K	$388.8K	$388.8K
YoY Change	-40.11%	-24.75%	-24.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$48.75K	$48.75K	$48.75K
YoY Change	0.0%		0.0%
Long-Term Debt Due	$867.0K	$1.320M	$1.320M
YoY Change	-25.39%		25.43%
Total Short-Term Liabilities	$1.135M	$1.787M	$1.787M
YoY Change	-35.65%	-4.32%	-4.32%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.135M	$1.787M	$1.787M
Total Long-Term Liabilities	$0.00		$0.00
Total Liabilities	$1.135M	$1.787M	$1.787M
YoY Change	-40.67%	-8.68%	-8.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.84M	-$17.72M
YoY Change	18.9%	8.78%
Common Stock	$20.10K	$19.06K
YoY Change	9.08%	-50.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K	$300.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.101M	-$1.705M	-$1.705M
YoY Change
Total Liabilities & Shareholders Equity	$33.72K	$82.06K	$82.06K
YoY Change	0.46%	-74.03%	-74.03%

Cashflow Statement

Concept	2024 Q1	2023 Q3	2023

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001792941
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q3	GNVR	Cooperative Research And Development Agreement Liabilities Current CooperativeResearchAndDevelopmentAgreementLiabilitiesCurrent		usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2023	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	GNVR	Founder Shares Issued Amount FounderSharesIssuedAmount		usd
	GNVR	Issuance Of Common Stock For Note Receivable Amount IssuanceOfCommonStockForNoteReceivableAmount		usd
	GNVR	Issuance Of Common Stock Value IssuanceOfCommonStockValue		usd
	GNVR	Issuance Of Common Stock For Settlements Amount IssuanceOfCommonStockForSettlementsAmount		usd
CY2023	GNVR	Stock Issued During Period Value Issuance Of Series Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesPreferredStock		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	GNVR	Conversion Of Liabilities Into Common Stock ConversionOfLiabilitiesIntoCommonStock		usd
	GNVR	Common Stock Issued For Interest Expense CommonStockIssuedForInterestExpense		usd
	GNVR	Effects Of Elimination Of Beneficial Conversion Feature EffectsOfEliminationOfBeneficialConversionFeature		usd
CY2023	GNVR	Beneficial Conversion Feature BeneficialConversionFeature		usd
CY2023	GNVR	Increase Decrease In Prepaid Costs For Reverse Capitalization IncreaseDecreaseInPrepaidCostsForReverseCapitalization		usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	GNVR	Discount On Notes Payable DiscountOnNotesPayable		usd
	GNVR	Non Cash Conversion Of Liabilities Into Common Stock NonCashConversionOfLiabilitiesIntoCommonStock		usd
	GNVR	Conversion Of Notes Payable Into Warrants ConversionOfNotesPayableIntoWarrants		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	GNVR	Fundraising Services FundraisingServices		usd
CY2023	GNVR	Fund Fund		usd
	GNVR	Fund Fund		usd
CY2023	GNVR	Prepaid Costs For Reverse Capitalization Recognized In Additional Paid In Capital PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital		usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56589
CY2023	dei	Entity Registrant Name EntityRegistrantName	GENVOR INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2054746
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 S. Elliott Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 538
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Chapel Hill
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27514
CY2023	dei	City Area Code CityAreaCode	984
CY2023	dei	Local Phone Number LocalPhoneNumber	261-7338
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	0	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19623536	shares
CY2023	dei	Auditor Firm AuditorFirmId	76
CY2023	dei	Auditor Name AuditorName	Turner, Stone & Company, L.L.P.
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q3	us-gaap	Cash Cash	44354	usd
CY2022Q3	us-gaap	Cash Cash	296386	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21975	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	66329	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	298386	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15734	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17565	usd
CY2023Q3	us-gaap	Assets Assets	82063	usd
CY2022Q3	us-gaap	Assets Assets	315951	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1319500	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1052000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	388809	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	270178	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	48750	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	48750	usd
CY2022Q3	GNVR	Cooperative Research And Development Agreement Liabilities Current CooperativeResearchAndDevelopmentAgreementLiabilitiesCurrent	246400	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1787059	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1621174	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	89221	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	89221	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1787059	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1710395	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19061936	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19061936	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38678155	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38678155	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	19062	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	38678	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16293188	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14608815	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17719307	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16041937	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1704996	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1394444	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82063	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	315951	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	377329	usd
	us-gaap	Professional Fees ProfessionalFees	233153	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	171856	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	284746	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	977235	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3512500	usd
CY2023	us-gaap	Depreciation Depreciation	1832	usd
	us-gaap	Depreciation Depreciation	1374	usd
CY2023	GNVR	Other General And Administrative Expenses OtherGeneralAndAdministrativeExpenses	-89566	usd
	GNVR	Other General And Administrative Expenses OtherGeneralAndAdministrativeExpenses	32108	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1438686	usd
	us-gaap	Operating Expenses OperatingExpenses	4063881	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1438686	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4063881	usd
CY2023	us-gaap	Interest Expense InterestExpense	43795	usd
	us-gaap	Interest Expense InterestExpense	51117	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-105000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5000	usd
CY2023	GNVR	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	120000	usd
	GNVR	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	90000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30111	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-268795	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-176228	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1707481	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4240109	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19545725	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19545725	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32437505	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32437505	shares
CY2021Q4	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-2237031	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3512225	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	165275	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1235555	usd
	GNVR	Adjustments To Additional Paid In Capital Payment For Reverses Capitalization AdjustmentsToAdditionalPaidInCapitalPaymentForReversesCapitalization	-150000	usd
	GNVR	Common Stock Issued To Prior Investors CommonStockIssuedToPriorInvestors	49725	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	269916	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4240109	usd
CY2022Q3	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-1394444	usd
CY2022Q3	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-1394444	usd
CY2022Q3	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-1394444	usd
CY2023	GNVR	Adjustments To Additional Paid In Capital Retrospective Adoption AdjustmentsToAdditionalPaidInCapitalRetrospectiveAdoption	-180668	usd
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	362525	usd
CY2023	GNVR	Stock Issued During Period Value Conversion Of Notes Payable In To Common Stock StockIssuedDuringPeriodValueConversionOfNotesPayableInToCommonStock	78633	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	354114	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	962900	usd
CY2023	GNVR	Stock Issued During Period Value Conversion Of Liabilities In To Common Stock StockIssuedDuringPeriodValueConversionOfLiabilitiesInToCommonStock	19335	usd
CY2023	GNVR	Issuance Of Common Stock For Legal Settlement IssuanceOfCommonStockForLegalSettlement	100090	usd
CY2023	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	300000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1707481	usd
CY2023Q3	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-1704996	usd
CY2023Q3	GNVR	Stockholders Equity Retractive Adjustment StockholdersEquityRetractiveAdjustment	-1704996	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1707481	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4240109	usd
CY2023	us-gaap	Depreciation Depreciation	1832	usd
	us-gaap	Depreciation Depreciation	1374	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	977235	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3512500	usd
CY2023	GNVR	Conversion Of Liabilities Into Common Stock ConversionOfLiabilitiesIntoCommonStock	19335	usd
CY2023	GNVR	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	120000	usd
	GNVR	Late Fee Capitalized Into Notes Payable LateFeeCapitalizedIntoNotesPayable	90000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-105000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5000	usd
CY2023	GNVR	Common Stock Issued For Interest Expense CommonStockIssuedForInterestExpense	6447	usd
CY2023	GNVR	Effects Of Elimination Of Beneficial Conversion Feature EffectsOfEliminationOfBeneficialConversionFeature	-150556	usd
	GNVR	Beneficial Conversion Feature BeneficialConversionFeature	-30111	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	21975	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1331	usd
	GNVR	Increase Decrease In Prepaid Costs For Reverse Capitalization IncreaseDecreaseInPrepaidCostsForReverseCapitalization	-150000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-2053	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-304437	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	139139	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-246400	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	26154	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	3846	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-871734	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-553235	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	265000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	354702	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	165000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	619702	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	465000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-252032	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-88235	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	296386	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	384621	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44354	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	296386	usd
	GNVR	Discount On Notes Payable DiscountOnNotesPayable	269916	usd
CY2023	GNVR	Conversion Of Note Payable Into Common Stock ConversionOfNotePayableIntoCommonStock	76325	usd
	GNVR	Conversion Of Note Payable Into Common Stock ConversionOfNotePayableIntoCommonStock	1235555	usd
CY2023	GNVR	Non Cash Conversion Of Liabilities Into Common Stock NonCashConversionOfLiabilitiesIntoCommonStock	19303	usd
CY2023	GNVR	Conversion Of Notes Payable Into Warrants ConversionOfNotesPayableIntoWarrants	350000	usd
	us-gaap	Stock Issued1 StockIssued1	49725	usd
	GNVR	Fundraising Services FundraisingServices	170000	usd
	GNVR	Prepaid Costs For Reverse Capitalization Recognized In Additional Paid In Capital PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital	150000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17719307	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1707481	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	871734	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zEDO7rw2jf28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zAXKitduhpCa">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
	us-gaap	Interest Expense Debt InterestExpenseDebt	141117	usd
CY2023	GNVR	Late Fees LateFees	120000	usd
	GNVR	Late Fees LateFees	90000	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	500000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	300000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1319500	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	164000	shares
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	1319500	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	989000	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	146946	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2316147	shares
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	76325	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	163795	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	569	shares
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.50
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	285	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	18144112	shares
CY2022Q2	GNVR	Number Of Shares Retained NumberOfSharesRetained	1855888	shares
	GNVR	Stock Issued During Period Shares Issued To Debt Holder StockIssuedDuringPeriodSharesIssuedToDebtHolder	5000	shares
	GNVR	Stock Issued During Period Value Issued To Debt Holder StockIssuedDuringPeriodValueIssuedToDebtHolder	2500	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	5000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2500	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	500000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	500000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	170000	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	25000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12500	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	29665	shares
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14833	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2497000	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2133000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-101591	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-204559	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-12578	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-25326	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	114169	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	229885	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	589214	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	503471	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	589214	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	503471	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	589214	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	503471	usd
CY2023Q3	GNVR	Deferred Tax Assets Net Valuation Allowance DeferredTaxAssetsNetValuationAllowance	2687054	usd
CY2022Q3	GNVR	Deferred Tax Assets Net Valuation Allowance DeferredTaxAssetsNetValuationAllowance	2572885	usd
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	19705	usd
CY2022Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	19705	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	2810	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	10187	usd
	us-gaap	Payments For Rent PaymentsForRent	30240	usd

Files In Submission

Name	View Source	Status
gnvr-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-002475-index-headers.html	Edgar Link	pending
0001493152-24-002475-index.html	Edgar Link	pending
0001493152-24-002475.txt	Edgar Link	pending
0001493152-24-002475-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
form10-k_006.jpg	Edgar Link	pending
form10-k_007.jpg	Edgar Link	pending
form10-k_008.jpg	Edgar Link	pending
form10-k_009.jpg	Edgar Link	pending
form10-k_010.jpg	Edgar Link	pending
form10-k_012.jpg	Edgar Link	pending
form10-k_013.jpg	Edgar Link	pending
form10-k_014.jpg	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
gnvr-20230930.xsd	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gnvr-20230930_pre.xml	Edgar Link	unprocessable
gnvr-20230930_cal.xml	Edgar Link	unprocessable
gnvr-20230930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Genvor Inc

2024 Q1 Form 10-K Financial Statement

#000149315224002475 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission